James Kulp

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

Neil A. Swanson, William Abramovits, Brian Berman et al. · Journal of the American Academy of Dermatology · 2010 · 149 citations

Imiquimod 2.5, Ophthalmology, Placebo-controlled Studies +7

A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.

Joseph L. Jorizzo, Orit Markowitz, Mark Lebwohl et al. · PubMed · 2010 · 47 citations

Strain differences in convulsive response to the excitotoxin kainic acid

Gregory T. Golden, George G. Smith, Thomas N. Ferraro et al. · Neuroreport · 1991 · 39 citations

Synaptic Transmission, Neurotransmitter, Neurotransmission +20

Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream.

C. William Hanke, Neil A. Swanson, Suzanne Bruce et al. · PubMed · 2011 · 36 citations

Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp

James Kulp, Sharon Levy, Melanie Fein et al. · Archives of Dermatological Research · 2010 · 17 citations

Actinic Keratoses, Face And/or, Ophthalmology +7